CLASS II Device recall · Reported 4 Jul 2018 · FDA Enforcement Report

RayStation Radiation Therapy Treatment Planning System recalled

Raysearch Laboratories AB is recalling RayStation Radiation Therapy Treatment Planning System, distributed nationwide in the US. The recall was initiated on 28 Mar 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes6.0.0.24 , 6.1.0.26 , 6.1.1.2 , 6.2.0.7 and 7.0.0.19
Quantity recalled728

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2290-2018
FDA event ID
80252
Recalling firm
Raysearch Laboratories AB, Stockholm
Classification
Class II
Status
Terminated
Recall initiated
28 Mar 2018
FDA classified
26 Jun 2018
Reported
4 Jul 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

28 Mar 2018Recall initiated by company
26 Jun 2018Classified by FDA+90 days
4 Jul 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The dose calculation accuracy may in some situations be less than expected. The user must be aware in order to avoid incorrect dose calculations during treatment planning.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RayStation Radiation Therapy Treatment Planning System; 6.0, 6.1, 6.2, 7.0 Product Usage: Usage: RayStation is a software system designed for treatment planning and analysis of radiation therapy. The treatment plans provide treatment unit set-up parameters and estimates of dose distributions expected during the proposed treatment, and may be used to administer treatments after review and approval by the intended user. The system functionality can be configured based on user needs. The intended users of RayStation shall be clinically qualified radiation therapy staff trained in using the system.

Where it was distributed

US Nationwide Distribution in the states of AL, AR, AZ, CA, CT, DC, DE, FL, GA, HI, ID, IL, MA, MD, ME, MI, MO, MS, MT, NC, NJ, NY, OH, OR, PA, TN, TX, UT, VA, VT, WA, WI.

Nationwide AlabamaArkansasArizonaCaliforniaConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaHawaiiIdahoIllinoisMassachusettsMarylandMaineMichiganMissouriMississippiMontanaNorth Carolina

Questions about this recall

Why was it recalled?

The dose calculation accuracy may in some situations be less than expected. The user must be aware in order to avoid incorrect dose calculations during treatment planning.

Which lots are affected?

6.0.0.24 , 6.1.0.26 , 6.1.1.2 , 6.2.0.7 and 7.0.0.19

Where was it sold?

US Nationwide Distribution in the states of AL, AR, AZ, CA, CT, DC, DE, FL, GA, HI, ID, IL, MA, MD, ME, MI, MO, MS, MT, NC, NJ, NY, OH, OR, PA, TN, TX, UT, VA, VT, WA, WI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Raysearch Laboratories AB

All 115

Other Medical Software recalls

All 903